tiprankstipranks

New Portfolio - New Portfolio

James Robinson

New Portfolio
Individual Investor
Ranked #289,293 out of 775,923 TipRanks' Investors
Success Rate
54%
162 out of 300
profitable transactions
Average Return
6.51%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 0.88%
6-Month Return▼ 5.60%
12-Month Return▲ 8.39%
YTD Return▲ 8.00%
Total Return▼ 15.72%

Best Trade

Opened at
Closed at-
Gain▲ 459.25%

Bio

This is my investment portfolio, I am a long term investor, although, their are times i make swing trades. I started investing 5 yrs ago.

Performance

43.22%0-43.22%
▲ 11.46%
▲ 5.06%
▲ 4.96%
May 2024
▼ 2.25%
▲ 3.53%
▲ 6.67%
Jun 2024
▲ 25.71%
▲ 1.21%
▲ 4.85%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 5.35%
Aug 2024
▲ 7.82%
▲ 2.10%
▼ 5.58%
Sep 2024
▲ 5.38%
▼ 0.89%
▼ 2.43%
Oct 2024
▲ 43.22%
▲ 5.96%
▲ 6.16%
Nov 2024
▲ 3.34%
▼ 1.56%
▼ 2.90%
Dec 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 11.46%▲ 5.06%▲ 4.96%
▼ 2.25%▲ 3.53%▲ 6.67%
▲ 25.71%▲ 1.21%▲ 4.85%
▼ 4.22%▲ 2.34%▼ 5.35%
▲ 7.82%▲ 2.10%▼ 5.58%
▲ 5.38%▼ 0.89%▼ 2.43%
▲ 43.22%▲ 5.96%▲ 6.16%
▲ 3.34%▼ 1.56%▼ 2.90%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Erasca
▲ 18.44%
2
Close
Sep 18, 2024
Fulcrum Therapeutics
▼ 56.34%
4
Close
Sep 18, 2024
Gladstone Capital
▲ 0.69%
2
Close
Sep 18, 2024
Immunic
▲ 26.58%
3
Close
Sep 18, 2024
Palantir Technologies
▲ 17.93%
2
Close
Sep 18, 2024
Robinhood Markets
3.57%
▲ 35.22%
6
Sell
Sep 02, 2024
Annexon Biosciences
▼ 1.54%
5
Close
Sep 02, 2024
Global X NASDAQ 100 Covered Call ETF
▲ 7.26%
2
Close
Sep 02, 2024
VICI Properties
▲ 12.25%
3
Close
Sep 02, 2024
Citius Pharmaceuticals
▼ 30.49%
2
Close
Sep 02, 2024
Tilray
▲ 3.43%
6
Close
Aug 26, 2024
SNDL
0.84%
▼ 16.88%
4
Buy
Aug 26, 2024
Microsoft
4.06%
▲ 24.83%
4
Buy
Aug 26, 2024
Meta Platforms
2.72%
▲ 85.35%
4
Buy
Aug 26, 2024
Alphabet Class A
1.78%
▲ 50.73%
4
Buy
Aug 26, 2024
Nvidia
6.34%
▲ 206.77%
4
Buy
Aug 26, 2024
Advanced Micro Devices
2.22%
▼ 0.09%
4
Buy
Aug 26, 2024
Oracle
1.58%
▲ 50.00%
3
Buy
Aug 26, 2024
Adverum Biotechnologies
5.29%
▼ 46.10%
5
Buy
Aug 26, 2024
Crispr Therapeutics AG
4.55%
▼ 29.48%
3
Buy
Aug 26, 2024